13F-HR filed by WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd. filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-06, with 5 holding rows worth $38,566,657.
- Accession
- 0001104659-24-011099
- Filer
- CIK 1832424
- Filed
- 2024-02-06
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 5 entries on the cover page, a total value of $38,566,657 stated on the cover page (in dollars after the unit check, H1), rows summing to $38,566,657 with VALUE read as dollars as filed, 13F file number 028-23614. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LYELL IMMUNOPHARMA INC | 55083R104 | COM | 8,180,678 | $15,870,515 | dollars as filed | |
| AMBRX BIOPHARMA INC | 641871108 | COM | 1,000,000 | $14,240,000 | dollars as filed | |
| ADAGENE INC | 005329107 | CMN | 4,225,696 | $8,161,509 | dollars as filed | |
| PURPLE BIOTECH LTD SPONSORED ADR | 74638P109 | ADR | 194,139 | $151,428 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 6,636 | $143,205 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-24-011099 | this filing | 2024-02-06 | acceptance time not in the bulk data set |